ERVW-1 and myeloid sarcoma: Higher levels of syncytin-1 in the brain of MS patients, compared to controls as well as multiple evidence showing that syncytin-1 induces inflammation, oxidative stress, and reduced myelin production in the brain, are proving probable relevance of syncytin-1 in the pathophysiology of MS.